FDA clears Chemence Medical’s new wound closure pen

[Image from Chemence Medical]Chemence Medical announced today that the FDA cleared its Exofin precision pen as a medical device for wound closure.

Alpharetta, Georgia-based Chemence said in a news release that the Exofin precision pen offers more versatility and exactness in closing wounds while also improving the ease of use in applying topical skin adhesive. It is available for immediate sale in the U.S.

The pen supplement’s Chemence’s portfolio of Exofin products, including the fast-drying 20ctyl cyanoacrylate topical adhesives with the highest viscosity formulation in the industry, the company said. Chemence offers new application methods, 30% increased viscosity and an industry-leading 14-day microbial barrier, it noted.

Chemence designed its Exofin pen as the only pen-style applicator on the market to feature an adjustable tip to allow the user to control the adhesive width by supporting three different application methods in one device: a…

Read more
  • 0